Akero Therapeutics, Inc.
AKRO
$42.60
-$0.25-0.58%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -2.35% | -24.05% | 35.10% | 29.30% | 18.88% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 40.90% | 252.70% | 174.34% | 39.51% | 320.75% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -1.47% | -21.74% | 37.58% | 29.67% | 20.65% |
|
|
|||||
| Total Current Assets | -1.47% | -21.74% | 37.58% | 29.67% | 20.65% |
| Net Property, Plant & Equipment | -31.00% | -28.45% | -26.41% | -23.25% | -21.88% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 28.22% | 26.70% | 42.33% | 28.68% | 30.32% |
|
|
|||||
| Total Accounts Payable | -9.05% | -21.42% | 28.26% | 120.21% | 43.94% |
| Total Accrued Expenses | 103.39% | 53.44% | 160.17% | 20.99% | 45.40% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4,921.09% | 11.99% | -44.25% | 12.30% | 12.24% |
| Total Finance Division Other Current Liabilities | 139.83% | -7.24% | -- | 37.55% | 42.74% |
| Total Other Current Liabilities | 139.83% | -7.24% | -- | 37.55% | 42.74% |
| Total Current Liabilities | 93.75% | 40.25% | 107.83% | 52.18% | 44.31% |
|
|
|||||
| Total Current Liabilities | 93.75% | 40.25% | 107.83% | 52.18% | 44.31% |
| Long-Term Debt | -36.61% | -17.22% | 41.39% | 54.26% | 41.37% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -45.21% | -39.87% | -35.41% | -31.87% | -28.83% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 143.90% | 66.29% | 259.26% | 118.28% | 92.94% |
| Total Liabilities | 24.42% | 9.10% | 68.52% | 51.78% | 41.39% |
|
|
|||||
| Common Stock & APIC | 34.45% | 34.32% | 42.03% | 35.35% | 35.20% |
| Retained Earnings | -41.55% | -42.94% | -43.91% | -45.72% | -42.60% |
| Treasury Stock & Other | 478.54% | 1,473.42% | 251.11% | 515.61% | -3.98% |
| Total Common Equity | 28.54% | 28.08% | 40.13% | 26.61% | 29.46% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 28.54% | 28.08% | 40.13% | 26.61% | 29.46% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 28.54% | 28.08% | 40.13% | 26.61% | 29.46% |
|
|
|||||